Doctors Note Logo

Published on: 3/9/2026

Is Farxiga Price Too High? Why Costs Vary & Medically Approved Next Steps

There are several factors to consider; for many paying out of pocket Farxiga can run about $500 to $650 per month, while insured costs can be $0 to $150 or even full price depending on coverage and assistance, reflecting its brand-only status, strong heart and kidney benefits, and the U.S. pricing system. See below to understand more.

If the price is a barrier, safe next steps include talking with your doctor before stopping or switching, checking your plan for formulary tier and prior authorization, using manufacturer savings or patient assistance, and discussing alternatives; see the complete guidance below because details can change the best choice for your situation.

answer background

Explanation

Is Farxiga Price Too High? Why Costs Vary & Medically Approved Next Steps

If you've looked up the Farxiga price recently, you may have felt sticker shock. Farxiga (dapagliflozin) is a brand-name prescription medication used to treat:

  • Type 2 diabetes
  • Heart failure (with reduced or preserved ejection fraction)
  • Chronic kidney disease (CKD)

It belongs to a class of drugs called SGLT2 inhibitors, which help the body remove excess glucose through the urine and provide heart and kidney protection beyond blood sugar control.

So, is the Farxiga price too high? The honest answer: for many people paying out of pocket, it can be expensive. But the actual cost varies widely depending on insurance coverage, location, and eligibility for assistance programs.

Let's break it down clearly and discuss medically appropriate next steps.


What Is the Typical Farxiga Price?

Without insurance, the retail Farxiga price in the United States can range from $500 to $650 per month for a 30-day supply (10 mg tablets), depending on the pharmacy.

However, what you actually pay may be very different.

Your out-of-pocket cost depends on:

  • Insurance coverage
  • Copay tier placement
  • Deductible status
  • Pharmacy pricing contracts
  • Eligibility for savings programs

For insured patients, monthly costs may range from:

  • $0–$50 with strong coverage
  • $50–$150 with higher copays
  • Full retail price if not covered

Because Farxiga is still brand-name (not generic in the U.S. at the time of writing), the price remains high compared to older diabetes medications like metformin.


Why Is the Farxiga Price So High?

Several factors influence pricing:

1. Brand-Name Drug Status

Farxiga is manufactured by AstraZeneca and remains under patent protection. Without generic competition, brand-name pricing remains elevated.

2. Research and Clinical Trials

Farxiga has undergone extensive clinical trials not only for diabetes but also for:

  • Heart failure
  • Chronic kidney disease

These expanded indications required large, multi-year studies involving thousands of patients. Research costs are often factored into pricing.

3. Expanded Benefits Beyond Glucose Control

Unlike older diabetes drugs, Farxiga has proven:

  • Reduction in heart failure hospitalizations
  • Slowing of kidney disease progression
  • Cardiovascular benefits in high-risk patients

These added benefits increase its perceived value in the healthcare system.

4. U.S. Drug Pricing Structure

Drug prices in the United States are not directly regulated in the same way as in many other countries. Negotiations between manufacturers, pharmacy benefit managers (PBMs), and insurers significantly affect final pricing.


Is Farxiga Worth the Cost?

This depends on your medical situation.

Farxiga may be especially valuable if you have:

  • Type 2 diabetes with heart disease
  • Heart failure (even without diabetes)
  • Chronic kidney disease
  • High risk of cardiovascular events

In these cases, Farxiga is not just a glucose-lowering drug — it is considered organ-protective therapy by major medical guidelines.

For some patients, the long-term benefits (fewer hospitalizations, slowed kidney decline) may outweigh the financial burden. For others, cost may be a barrier that requires alternative options.


Medically Approved Next Steps if the Farxiga Price Is Too High

If you're concerned about the Farxiga price, here are safe and appropriate actions:

1. Speak to Your Doctor

This is the most important step.

Ask:

  • Is Farxiga essential for my condition?
  • Are there lower-cost alternatives?
  • Do I qualify for other SGLT2 inhibitors that may be covered differently?

Never stop the medication abruptly without medical guidance, especially if you are taking it for heart failure or kidney disease.


2. Review Insurance Coverage

Contact your insurer and ask:

  • Is Farxiga on my formulary?
  • What tier is it?
  • Is prior authorization required?
  • Are there preferred alternatives?

Sometimes a simple prior authorization can significantly reduce cost.


3. Manufacturer Savings Programs

Many pharmaceutical companies offer:

  • Copay cards for commercially insured patients
  • Patient assistance programs for low-income individuals

These can reduce monthly costs substantially if you qualify.


4. Consider Therapeutic Alternatives

Depending on your diagnosis, your doctor may discuss:

  • Other SGLT2 inhibitors
  • GLP-1 receptor agonists
  • Older, lower-cost diabetes medications
  • ACE inhibitors or ARBs for kidney protection
  • Beta blockers or other heart failure medications

Each alternative has pros and cons. The right choice depends on your full medical history.


When Cost Should NOT Be the Only Factor

If you have:

  • Worsening heart failure symptoms (shortness of breath, swelling)
  • Progressive kidney disease
  • Poorly controlled diabetes

Cost concerns are valid — but untreated or undertreated disease can lead to:

  • Hospitalization
  • Dialysis
  • Cardiovascular events
  • Permanent organ damage

In these cases, speak to a doctor promptly. There may be financial solutions that allow you to stay on the medication safely.


Could You Have Undiagnosed Diabetes?

If you're researching the Farxiga price, you may already have diabetes — or be concerned you might.

Common symptoms of diabetes include:

  • Increased thirst
  • Frequent urination
  • Unexplained weight loss
  • Fatigue
  • Blurred vision
  • Slow-healing wounds

If you're experiencing any of these symptoms and want to understand your risk level before seeing a doctor, you can use a free AI-powered Diabetes Mellitus symptom checker to evaluate your symptoms in just a few minutes and get personalized guidance on next steps.

That said, an online tool does not replace proper medical testing. A blood test is required for diagnosis.


Is the Farxiga Price Likely to Drop?

Drug prices often decrease when:

  • Generic versions enter the market
  • Patents expire
  • Insurance negotiations change
  • Policy reforms impact pricing

However, significant price reductions may take time. If affordability is a concern today, practical solutions through insurance review and doctor consultation are more realistic than waiting for price changes.


Safety Considerations

Farxiga is generally well tolerated, but possible side effects include:

  • Genital yeast infections
  • Urinary tract infections
  • Increased urination
  • Dehydration
  • Rare but serious: diabetic ketoacidosis

Seek immediate medical care if you experience:

  • Severe abdominal pain
  • Nausea and vomiting
  • Rapid breathing
  • Confusion
  • Signs of severe infection

These symptoms can be serious and require urgent evaluation.


The Bottom Line: Is the Farxiga Price Too High?

For uninsured patients, the Farxiga price can be high — often several hundred dollars per month. For insured patients, costs vary widely.

However:

  • Farxiga has strong evidence supporting heart and kidney protection.
  • It is considered guideline-recommended therapy for multiple serious conditions.
  • There are medically appropriate financial assistance and alternative options available.

If cost is preventing you from taking your medication as prescribed, do not ignore the issue. The safest next step is to speak to a doctor about your options. Untreated diabetes, heart failure, or kidney disease can become life threatening if not properly managed.

Open communication with your healthcare provider is not only appropriate — it is essential.

Your health matters. Cost matters too. The goal is to address both responsibly and safely.

(References)

  • * Li H, Yang Z, Lu Y, Sun M, Wang J, Lu W, Hu R. Economic evaluation of SGLT2 inhibitors in heart failure and chronic kidney disease: A systematic review and meta-analysis. Front Pharmacol. 2023 Sep 21;14:1260388. doi: 10.3389/fphar.2023.1260388. PMID: 37780825.

  • * Ma J, Zhang P, Chen X, Liu R, Dong Z. Cost-effectiveness of dapagliflozin for heart failure with reduced ejection fraction and type 2 diabetes in the US. J Med Econ. 2023 Mar;26(1):285-293. doi: 10.1080/13696998.2023.2173163. PMID: 36762283.

  • * Kamal T, Adeli K, Lang J, Lamy V, Singh M, Cattran D. Cost-Effectiveness of Dapagliflozin for the Treatment of Chronic Kidney Disease in Canada. PharmacoEconomics. 2022 May;40(5):497-511. doi: 10.1007/s40273-022-01126-7. Epub 2022 Mar 4. PMID: 35246757.

  • * Zhang M, Liu J, Wang Z, Han Y, Yu R, Yang M, Li R, Yu H, Wang C. Cost-effectiveness of dapagliflozin versus standard of care for patients with heart failure with reduced ejection fraction in China. Front Pharmacol. 2023 May 3;14:1169046. doi: 10.3389/fphar.2023.1169046. PMID: 37199047.

  • * Ma J, Zhang P, Hu Q, Han X, Dong Z. Out-of-pocket costs for SGLT2 inhibitors and GLP-1 receptor agonists in Medicare Part D beneficiaries with type 2 diabetes. J Med Econ. 2020 Jan-Dec;23(1):33-40. doi: 10.1080/13696998.2019.1697970. Epub 2019 Nov 25. PMID: 31766914.

Thinking about asking ChatGPT?Ask me instead

Tell your friends about us.

We would love to help them too.

smily Shiba-inu looking

For First Time Users

What is Ubie’s Doctor’s Note?

We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.

Learn more about diseases

Diabetes Mellitus

Was this page helpful?

Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.